Roanoke Times Copyright (c) 1995, Landmark Communications, Inc. DATE: THURSDAY, August 12, 1993 TAG: 9308120233 SECTION: NATIONAL/INTERNATIONAL PAGE: A-12 EDITION: METRO SOURCE: Associated Press DATELINE: BOSTON LENGTH: Short
The idea of arming disease-seeking antibodies with bits of poison or radioactive material has been around for years. Until now, though, efforts to use the technology against cancer have been disappointing.
However, in a report published in today's New England Journal of Medicine, doctors describe unusually impressive results of a new attempt to harness this approach.
They conducted a preliminary study on nine lymphoma patients who had failed to respond to chemotherapy. The test was intended only to see if the treatment was safe.
But to the doctors' surprise, the cancer vanished in four of them. Two remain apparently cancer-free after more than a year.
"This is a lot better than we would ever have hoped for," said Dr. Mark Kaminski of the University of Michigan. "Patients [are] going into complete remission. One patient had a pound of tumor in his abdomen, and it shrank away to nothing with minimal side effects."
The researchers used the new therapy to treat cancer of the B cells, a variety of white blood cells that manufacture disease-fighting antibodies. Kaminski said about 32,000 new cases are diagnosed in the United States annually.
by CNB